Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 35, 415-422, February 1, 1975]
© 1975 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plunkett, W.
Right arrow Articles by Cohen, S. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Plunkett, W.
Right arrow Articles by Cohen, S. S.

Metabolism of 9-ß-D-Arabinofuranosyladenine by Mouse Fibroblasts1

William Plunkett and Seymour S. Cohen

Department of Microbiology, University of Colorado Medical Center, Denver, Colorado 80220

The metabolism of 9-ß-D-arabinofuranosyladenine (araA) by exponentially growing mouse fibroblasts in suspension culture has been investigated. After a 4-hr incubation with 0.1 mM [3H]araA, only 0.14% of the total 3H was in the cell fraction, whereas 48% of the araA in the medium had been deaminated to 9-ß-D-arabinofuranosylhypoxanthine. Of the cellular 3H, 80% was acid soluble, and of these 75% was associated with adenine nucleotides and 25% was associated with nucleosides. 9-ß-D-arabinofuranosylhypoxanthine comprised 80% of the labeled nucleosides, the rest being araA or adenosine. Following dephosphorylation of the acid-soluble fraction, 80% of the 3H was in araA and 9-ß-D-arabinofuranosylhypoxanthine, and 18% was in adenosine. Ninety % of the 3H in the adenine-containing triphosphates was shown to be in arabinosyl compounds, and the remainder was in adenosine and deoxyadenosine. The concentration of cellular 9-ß-D-arabinofuranosyladenine 5'-triphosphate was calculated to be 20 µM.

The RNA fraction contained 16% of the total cellular 3H. Over 90% of the 3H was associated with the adenosine 2'(3')-phosphate fraction; the remainder was nucleoside, mainly araA. When the adenosine 2'(3')-phosphate fraction was dephosphorylated, nearly 70% of the 3H was contained in adenosine, indicating extensive metabolism of araA. The remaining 3H was associated with arabinosyl compounds.

The DNA fraction contained 2% of the cellular 3H. After degradation to 5'-monophosphates, the 3H was found mainly in 9-ß-D-arabinofuranosyladenine 5'-phosphate; after dephosphorylation 95% of the 3H was in araA. Following degradation to 3'-monophosphates and terminal nucleosides, the majority of the 3H was associated with 9-ß-D-arabinofuranosyladenine 3'-phosphate, whereas a minor portion was in the nucleoside.

These results suggest that, after incubation with mouse fibroblasts, most of the exogenous araA is deaminated and remains in the medium or is otherwise metabolized. A small amount is phosphorylated to arabinosyl nucleotides that attain inhibitory cellular concentrations, and some 9-ß-D-arabinofuranosyladenine 5'-triphosphate is subsequently incorporated in internucleotide linkage into DNA.

1 This study was supported by Grant NP-60B from the American Cancer Society, Grant 1 RO1 AI 11636-01 from the National Institute of Allergy and Infectious Diseases, and a grant from the Upjohn Company.

Received 4/24/74. Accepted 10/15/74.




This article has been cited by other articles:


Home page
BloodHome page
C. O. Rodriguez Jr, C. M. Stellrecht, and V. Gandhi
Mechanisms for T-cell selective cytotoxicity of arabinosylguanine
Blood, September 1, 2003; 102(5): 1842 - 1848.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1975 by the American Association for Cancer Research.